Status:
ACTIVE_NOT_RECRUITING
Feasibility Neurocognitive Outcome After Transplant
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Thrasher Research Fund
Conditions:
Stem Cell Transplantation
Pediatric Cancer
Eligibility:
All Genders
6-21 years
Phase:
NA
Brief Summary
This pilot study will primarily be evaluated by feasibility and adherence to an iPad-based neurocognitive intervention program. It will secondarily be evaluated by performance on the neurocognitive te...
Eligibility Criteria
Inclusion
- All patients must have a histologic or cytological diagnosis of ALL treated with stem cell transplantation. There are no restrictions on prior therapy.
- Patients must be between the ages of 6 years and 21 years of age (inclusive), but there will be no discrimination based on gender, race, creed, or ethnic background. The age limits are set at 6 years of age in order to ensure that patients will be able to participate in these specific cognitive rehabilitation tasks. ECOG/KPS will not be employed.
- Patient and/or parents/guardians as appropriate must sign an informed consent, be mentally responsible, able to understand and willing to sign a written informed consent.
Exclusion
- Subjects with significant concurrent medical complications that in the judgment of the Principal Investigator(s) could affect the patient's ability to complete the planned trial. There are no therapy restrictions or restrictions regarding the use of other Investigational Agents.
- Pregnant patients will be excluded.
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2025
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT02300961
Start Date
December 1 2014
End Date
November 1 2025
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University, School of Medicine
Palo Alto, California, United States, 94304